Ovarian cancer: NHS approves ‘first in over 20 years’ drug that offers women more time and better quality of life
etimes.in / Jun 04, 2026, 11:43 (IST)
A groundbreaking drug, Elahere, has been approved in the UK, offering new hope for women with advanced ovarian cancer resistant to chemotherapy. This targeted therapy, an antibody-drug conjugate, delivers treatment directly to cancer cells, minimizing side effects. Clinical trials show it significantly extends survival and slows disease progression, marking a major advance in treatment options.